Digoxin
Digoxin is used for treating heart failure and slowing the heart rate in patients with chronic atrial fibrillation, a type of abnormal heart rhythm.
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.53 | $48.00 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $64.00 $59.00 (8%) | 🛒 Add to cart |
| 180 | $0.46 | $96.00 $83.00 (14%) | 🛒 Add to cart |
| 270 | $0.43 | $144.00 $117.00 (19%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $192.00 $152.00 (21%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Azithromycin DT: Effective Bacterial Infection Treatment with Convenient Dosing
Azithromycin Dispersible Tablets (DT) represent a significant advancement in antibiotic therapy, offering healthcare professionals and patients a reliable, well-tolerated treatment option for various bacterial infections. This macrolide antibiotic combines broad-spectrum antibacterial activity with exceptional pharmacokinetic properties, including extensive tissue penetration and a prolonged elimination half-life that permits once-daily dosing. The dispersible tablet formulation enhances patient compliance, particularly in pediatric, geriatric, and dysphagic populations, while maintaining the established efficacy profile of azithromycin.
Azithromycin: Effective Broad-Spectrum Antibiotic Treatment
Azithromycin is a macrolide antibiotic indicated for the treatment of a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted diseases. Its extended half-life and tissue-penetrating properties allow for convenient once-daily dosing and shorter treatment courses compared to many alternatives. This medication works by inhibiting bacterial protein synthesis, effectively stopping the growth of susceptible bacteria. Proper diagnosis and prescription by a healthcare professional are essential for appropriate use.
Bactrim: Potent Dual-Antibiotic Therapy for Bacterial Infections
Bactrim is a combination antibiotic medication containing sulfamethoxazole and trimethoprim. It belongs to the class of drugs known as sulfonamides and works synergistically to inhibit successive steps in the biosynthesis of nucleic acids and proteins essential to many bacteria. This dual-action mechanism provides a broad spectrum of bactericidal activity against a wide array of susceptible organisms. It is a cornerstone in the treatment of various common and opportunistic infections, particularly when resistance to single-agent antibiotics is a concern.
Erythromycin: Broad-Spectrum Antibiotic for Bacterial Infection Control
Erythromycin is a macrolide-class antibiotic with established efficacy against a wide range of gram-positive and some gram-negative bacteria. It functions by inhibiting bacterial protein synthesis, effectively halting microbial replication. This agent is particularly valuable for patients with penicillin allergies and remains a cornerstone in treating respiratory, skin, and soft tissue infections. Its well-documented pharmacokinetic profile and multiple formulation options support tailored therapeutic approaches across diverse patient populations. Features Belongs to the macrolide antibiotic class Available in oral (tablet, capsule, suspension), topical, and ophthalmic formulations Bacteriostatic action through 50S ribosomal subunit binding Effective against Streptococcus, Staphylococcus, Mycoplasma, and Chlamydia species Multiple ester forms (e.
Ilosone: Potent Macrolide Antibiotic for Bacterial Infection Resolution
Ilosone (erythromycin estolate) is a cornerstone macrolide antibiotic medication with a well-established efficacy profile against a wide spectrum of Gram-positive and some Gram-negative bacteria. It functions by inhibiting bacterial protein synthesis, effectively halting the growth and proliferation of susceptible organisms. This makes it a trusted choice for healthcare professionals in treating various respiratory, skin, and soft tissue infections. Its formulation is designed for reliable systemic absorption, ensuring therapeutic drug levels are achieved to combat bacterial pathogens effectively.
Ivermectol: Targeted Parasite Control with Precision Efficacy
Ivermectol represents a significant advancement in antiparasitic therapy, offering healthcare professionals a potent and selective treatment option for a range of parasitic infestations. As a semi-synthetic derivative of avermectin, it exhibits high affinity for glutamate-gated chloride channels found in nerve and muscle cells of invertebrates, leading to increased cell permeability, paralysis, and death of parasites. Its broad-spectrum activity and well-characterized pharmacokinetic profile make it a cornerstone in both human and veterinary medicine for managing nematode and arthropod infections.
Roxithromycin: Advanced Macrolide Therapy for Bacterial Infections
Roxithromycin is a semi-synthetic macrolide antibiotic derived from erythromycin, designed to offer enhanced pharmacokinetic properties and a broad spectrum of antibacterial activity. It functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, effectively treating a range of community-acquired infections. Its improved acid stability and tissue penetration make it a reliable choice for respiratory, skin, and soft tissue infections, particularly where penicillin intolerance exists. This agent is valued for its convenient once- or twice-daily dosing and generally favorable tolerability profile.
Rulide: Advanced Macrolide Therapy for Respiratory Infections
Rulide (roxithromycin) is a semi-synthetic macrolide antibiotic specifically engineered to target a broad spectrum of bacterial pathogens responsible for upper and lower respiratory tract infections. Its advanced molecular structure provides enhanced stability against gastric acid degradation, resulting in superior bioavailability and predictable pharmacokinetics compared to earlier macrolides. Clinicians favor Rulide for its targeted efficacy, favorable tolerability profile, and convenient once-daily dosing regimen that supports patient adherence. This next-generation antibiotic represents a cornerstone in empirical and directed antimicrobial therapy for community-acquired infections.
Zithromax: Effective Broad-Spectrum Antibiotic Treatment
Zithromax (azithromycin) is a macrolide antibiotic renowned for its potent activity against a wide range of bacterial pathogens. It is indicated for the treatment of numerous community-acquired infections, including respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted diseases. Its extended half-life allows for convenient once-daily dosing and shorter treatment courses compared to many alternatives, promoting enhanced patient adherence. Zithromax is available in oral and intravenous formulations, making it a versatile option in both outpatient and clinical settings.